期刊文献+

比较奥氮平与氟哌啶醇对青年精神分裂症患者血清生长激素的影响 被引量:5

Comparison on the effects of olanzapine and haloperidol for growth hormonal levels in juvenile younger schizophrenia
下载PDF
导出
摘要 目的比较研究奥氮平和氟哌啶醇对青年精神分裂症患者生长激素(GH)水平的影响。方法用化学发光法测定51例青年精神分裂症患者奥氮平与氟哌啶醇治疗前后的GH水平,并与20例健康者作对照。奥氮平组29例,剂量(14±7)mg·d-1,氟哌啶醇组22例,剂量(26±8)mg·d-1,均疗程8周。结果治疗前,青年精神分裂症患者(含2组)与健康者GH分别为(2.24±1.32),(2.48±1.67)μg·L-1(P>0.05)。治疗8周后,奥氮平组于治疗前后的GH分别为(2.62±1.40),(2.30±1.51)μg·L-1,差异无统计学意义(P>0.05);而氟哌啶醇GH分别为(1.42±0.87),(2.49±1.10)μg·L-1,差异有统计学意义(P<0.01)。结论氟哌啶醇能使青年精神分裂症患者GH水平显著降低;而奥氮平对青年精神分裂症患者GH水平无明显影响,安全性较好。 Objective To compare the hormone change after olanzapine and haloperidol treatment for juvenile younger schizophrenia. Methods Chemiluminescence immunoassay were used to examine serum level of growth hormone in 51 juvenile younger schizophrenia before and after treatment. The 51 patients were randomly assigned to olanzapine group 29 case, dose was (14 ±7)mg· d-1, and haloperidol group 22 cases, dose was (26 ± 8)mg· d-1, the treatment duration was 8 weeks in both two groups. The 20 healthy volunteers was normal as control group. Results Before treatment the growth hormone level of patients was (2.24 ± 1.32) mg· d-1 ; control group was (2.48 ± 1.67) mg· d-1 .There was no difference of serum growth hormone level between two groups (P 〉 0.05). After 8 weeks treatment of olanzapine, the growth hormone level of patients was ( 2.62± 1.40) mg· d-1 , no significantly higher than(2.30± 1.51 ) mg· d-1 before trenatment ( P 〉 0.05 ). After 8 weeks treatment of haloperidol, the growth hormone level of patients was ( 1.42 ± 0.87 ) mg· d-1, significantly lower than (2.49 ± 1. 10) mg· d-1before trenatment ( P 〈 0.01 ). Conclusion Haloperidol reduced growth hormone levels in juvenile schizophrenia, while olanzapine had no effect on the growth hormone levels.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2010年第4期248-250,共3页 The Chinese Journal of Clinical Pharmacology
基金 江苏省无锡市科技发展基金资助项目(CS030001)
关键词 精神分裂症 生长激素 奥氮平 氟哌啶醇 schizophrenia growth hormone olanzapine haloperidol
  • 相关文献

参考文献10

  • 1中华医学会精神病学分会.中国精神障碍分类与诊断标准(第3版).中华精神科杂志,1997,30:184-188.
  • 2WHO(郝伟,张亚林,杨坚,等译).精神障碍国际分类法(第10版)草案[M].长沙:湖南医科大学精神卫生研究所,1998:2-9.
  • 3Keks NA, Copolov DL, Kulkarni J, et al. Basal and haloperidol stimulated prolaetin in neuroleptie - free men with schizophrenia defined by 11 diagnostic systems[ J]. Biol Psychiatry, 1990 ;27 : 1203 - 1205.
  • 4徐贵云,侯静,马崔,吴福喜,黎德美,陆欣乔,朱海兵.利培酮与氟哌啶醇对女性首发精神分裂症患者血清催乳素水平的影响[J].中国神经精神疾病杂志,2001,27(6):454-455. 被引量:20
  • 5Jung HL, Jong IW, Herbert YM. Effects of clozapine on sleep measures and sleep associared changes in growth hormone and cortisol in patients with schizophrenia [ J ]. Psychiat Res, 2001 ; 103 : 157 - 166.
  • 6Kapur S, Zipursky RB, Remington G, et al. Clinical and theoretical implications of 5 - HT2 and D2 receptor occupancy of clozapine,risperidone, and olanzapine in schizophrenia [ J ]. Am J Psychiatry, 1999 ; 156:286 - 289.
  • 7Meitzer HY. An overt'Jew of the mechanism of action of clozapine [ J ]. J Clin Psychiatry, 1999 ;55 ( Suppl. 13 ) :S47 - S51.
  • 8陈灏珠.实用内科学(第10版)[M].北京:人民卫生出版社,1998.1027.
  • 9Rosenheck R, Perlick D, Bingham S, et al. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a tan. domized controlled trial [ J ]. JAMA,2003 ;290:2693 - 2697.
  • 10Canas F, Ciudad A , Gutierrez M , et al. Safety, effectiveness, and patterns of use of olanzapine in acute schizophrenia: a multivariate a. nalysis of a large naturalistic study in the hospital setting[ J]. Med Clin, 2005 ; 124:481 - 483.

二级参考文献5

共引文献29

同被引文献24

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部